Andrew J Sauer MD

My top ten tips for graduating fellows and faculty entering and continuing “early career” as I am transitioning into “mid-career”. A thread:

Academic publishing is long overdue for real disruption. As I’ve been posting about recently, the current system is fundamentally broken: paywalls that block access to research, sky-high article processing charges that favor well-funded labs, months-long review cycles that slow down medical progress, and peer reviewers who do the heavy lifting for free with zero recognition or career benefit. We are introducing OpenSource: Cardiology, a physician-led option built by and for the cardiovascular community. 🔓 100% open access - free for every reader, worldwide 💵 Zero publication fees for original research (sustainably funded, not on authors) ©️ Authors retain full ownership of their work 🤖 Smart AI to accelerate submissions, reviewer matching, formatting, and integrity checks - without replacing human scientific judgment 🧠 Reimagined peer review with actual incentives: gift cards, opportunities to publish editorials and earn co-authorship, and paths to advancement in the editorial team We are open for business! Follow us @opensourcecards, submit your manuscripts, and signup as a reviewer at opensourcecardiology.org. Join us and be part of the solution! Thanks to everyone who has advised @jtsaxon and I on this journey including @djc795 @CMichaelGibson @DrDamluji @AndrewJSauer @heartofthemater @ShahzebKhanMD @MichaelNassifMD @venkmurthy @AmitGoyalMD @JavedButler1 and others!

@BrettSperryMD and I are starting a new medical journal: OpenSource Cardiology opensourcecardiology.org Learn more here 👇🏻

Academic publishing is overdue for reinvention. Introducing OpenSource: Cardiology—a physician-led, nonprofit, fully open-access journal built by and for the cardiovascular community. Better science. Broader access. A fairer system. opensourcecardiology.org

Kansas City welcomed the world 🫶 The smallest host city, the largest impact. Proud. Thank you @FIFAWorldCup for the memories 🩵

Nothing says ‘we value your contribution to science’ quite like asking uncompensated reviewers to improve a paper so we can charge the authors thousands of dollars to publish it. It’s time for a change…

And so, the World Cup’s stay in Kansas City has come to an end. And it ended the same way it began 25 days ago, with an Argentinian celebration. The greatest sporting event in the world outside of the Olympics came to our city and we did more than just hold our own, we dominated. We didn’t just host the party — provide the venue, the refreshments, the music — we did a stage dive right into the middle of it. And our guests took note. Teams, fans, media, everyone was over the moon about Paris of the Plains. This was a transformational moment in the history of this place we call home. So many people fall in love over one summer with someone they never met before. I feel like we’re going to look back at this as the summer when the world fell in love with Kansas City.

Have you ever been frustrated by unnecessary and tedious formatting and data entry requirements when submitting a paper to a medical journal? I sure wish there was an easier alternative…

APCs in the $1000s. Copyright transfer. Paywalls. Free labor. Academic publishing is long overdue for a physician-led alternative. Stay tuned! @jtsaxon @AndrewJSauer @MichaelNassifMD @djc795 @CMichaelGibson @AmitGoyalMD @anish_koka @venkmurthy @MaggieInfeld @chetanhuded

Only 18% of eligible patients with HFrEF get all 4 class 1, ☠️ ⬇️ GDMT 💊 🤯 Substantial implementation gap 🚧 GDMT works when Rxed and adhered to ✅ Make the system work for patients with HFrEF 🛠️ Quadruple GDMT for all eligible, now 🎯 #HeartFailure #Cardiology #GDMT

You heard it here first: Big announcement coming early next week. Stay tuned! @BrettSperryMD @CMichaelGibson @djc795 @MichaelNassifMD

Latest ICYMI from JCF Key HF insights from the recent HFA meeting in May @escardio It's tough to keep up with all the practice-changing insights from the various meetings - at JCF, we've got you! @PaulaRambarat @jozinetm onlinejcf.com/article/S1071-…

Excited to share our new publication in JACC: Heart Failure evaluating a wearable-based AI approach to monitoring patients with HFrEF. Heart failure deterioration uncommonly begins on the day a patient is hospitalized. The challenge is identifying subtle physiologic change early enough to prompt clinical review, without adding more burden to patients or clinicians. In TRIBE-HF II, we studied CardioID, a passive smartwatch-enabled platform using heart-rate–derived physiologic patterns and baseline/serial NT-proBNP context to detect NT-proBNP–defined worsening HF. In the validation cohort, the algorithm demonstrated strong diagnostic performance and earlier alerting compared with conventional weight-based monitoring. The important signal is that passive longitudinal physiology may help us bridge the gap between episodic clinic/lab assessment and invasive monitoring strategies. This is where the wearable space needs to move: away from single data streams and consumer wellness signals alone, and toward clinically anchored algorithms that are validated against meaningful HF biology and eventually tested for impact on treatment decisions and outcomes. The next step is larger prospective validation across broader HF populations, different wearable platforms, and real-world care workflows. But this study is an encouraging step toward scalable, lower-burden ambulatory HF surveillance. Proud to be part of this work with the TRIBE-HF investigators. doi.org/10.1016/j.jchf…

@HCPLiveCardio @Spotify @YouTube @ApplePodcasts @DrMarthaGulati @AndrewJSauer Here's the link to all of the podcasts! hcplive.com/podcasts/movin…

Excited to share Episode 4 of Moving the Needle in Medicine with @dranulala, produced by @HCPLiveCardio. hcplive.com/view/moving-th… Dr. Anu Lala's path to advanced heart failure began long before medical school, after helping care for her grandmother during a heart attack alongside her father, a cardiologist. On this episode, she reflects on the mentors, training experiences, and first heart transplant that shaped her career—and why heart failure is ultimately about understanding patients as much as treating disease.

Don’t “treat” HR 130, especially if it’s sinus rhythm. Diagnose the underlying cause, and then treat that cause. There are very few exceptions to this general rule, such as dynamic outflow tract obstruction or severe mitral stenosis with acute pulmonary edema with decompensated RV failure in the setting of acute tachycardia.

Good example of strategy in life. 90% positioning, 10% explosive execution when the timing is right. Activity without achievement is a false god of the modern world.

Can we apply a class effect to cardiovascular devices the same way we do for drugs? Our Heart of the Matter Cardio Pod tackles this timely question with an expert panel discussing evidence, regulatory considerations, and real-world implications. 🎧 youtu.be/401h9fRVjRI?is…